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Abstract
Impedance cardiography (IC) measures cardiovascular hemodynamics noninvasively during exercise. However, IC measurements assessing physiological differences
across treadmill (TM) and cycle (CYC) exercise has not been investigated. The purpose
of this study is to investigate whether hemodynamic measurements assessed via IC are
consistent between TM and CYC exercise at two absolute exercise intensities. Twenty-one
men (age = 21.4  0.5 y; BMI = 24.4  0.5) completed four exercise tests, two TM and two
CYC. Within each test, two, five-minute, steady-state stages were completed with targeted
intensities of 5 (MODex) and 7 (VIGex) metabolic equivalents (METs). Oxygen
consumption (VO2) was measured by indirect calorimetry. Hemodynamic measures were
obtained via IC (PhysioFlow, PF07 Enduro) and included cardiac output (CO), heart rate
(HR), stroke volume (SV), end diastolic volume (EDV), ejection fraction (EF), systemic
vascular resistance (SVR), contractility index (CTi), and left cardiac work index (LCWi).
Within treadmill exercise, there were no main effects for trial, except for HR. There were
no main effects for trial within CYC exercise. Across exercise modes, there were no
significant differences between TM and CYC exercise for all variables, with the exception
of higher HR in CYC, and higher SV and EDV in TM. ICCs were strong for all variables
except VIGex SVR and VIGex LCWi. IC hemodynamic measurements showed strong
repeatability across modes for all hemodynamic variables during MODex. For VIGex, all
variables showed strong correlations, except for SVR and LCWi. Lack of agreement may
be associated with daily variation in hemodynamics or physiological differences across
modes with the remainder of discrepancies associated with device error.

vi

Chapter 1
Introduction
Hemodynamics during Exercise
In cardiovascular physiology, hemodynamics relates to blood circulation. The heart
ejects blood each beat in order to deliver oxygen throughout the body. The amount of blood
pumped into the aorta per beat is known as stroke volume (SV), which when multiplied by
heart rate (HR) determines cardiac output (CO) (American College of Sports Medicine and
Ehrman, 2014). CO is the central limiting factor in an individual’s VO2 max, which
represents the greatest amount of oxygen that can be consumed and utilized in the muscle
tissues. Average resting SV values range from 60-100mL/beat. This discrepancy can be
attributed to body size and training status (American College of Sports Medicine and
Ehrman, 2014). Larger individuals will have a greater SV compared to smaller individuals.
Furthermore, trained athletes will have a greater SV, compared to untrained individuals,
due to increased blood volume allowing for a greater venous return and end diastolic
volume (EDV), which stretches the myocardium causing a more efficient contraction
compared to untrained individuals (Ekblom et al., 1968; American College of Sports
Medicine and Ehrman, 2014). Likewise, endurance training increases left ventricular mass
and compliance that leads to decreases in afterload and end systolic volume (ESV)
producing a larger SV (Howden et al., 2015). Up to 40% VO2 max, SV increases to 100120mL/beat in the average person. Beyond that point, increases in HR have a greater
influence on the increases in CO (Ekblom et al., 1968; American College of Sports
Medicine and Ehrman, 2014). In endurance trained athletes, SV may reach 200mL/beat
through maximal exercise without a plateau leading to greater CO compared to untrained
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individuals (Gledhill, Cox and Jamnik, 1994). There are several methods that can be used
to measure CO.

Measuring Cardiac Output
The direct Fick method and dye dilution are considered the “gold standards” for
measuring CO (Warburton et al., 1999). Both methods use catheters in or near the heart.
The direct Fick method allows for the simultaneous collections of arterial and venous
blood, so the atrial-venous oxygen difference (a-vO2) can be calculated. SV can then be
calculated using the Fick Equation since HR is known (Cournand et al., 1945). In the dye
dilution technique, a known amount of dye is injected into the vena cava or pulmonary
artery. A densitometer measures the downstream blood flow calculating SV from the
change in fluid density (Ekblom et al., 1968). Thermodilution is a similar technique to dye
dilution, but a cold solution of a given temperature is injected instead of dye. The change
in temperature of the infused solution is used to calculate SV (Scherhag, Kaden and
Kentschke, 2005). Although these methods are considered valid (Cournand et al., 1945;
Ekblom et al., 1968; Warburton et al., 1999), their invasive nature can make them difficult
to utilize during exercise. These issues led to the development several of non-invasive CO
measuring techniques.
Non-invasive methods used to calculate CO include CO2 rebreathing (Faulkner et
al., 1971), acetylene rebreathing (Bell et al., 2003), inert gas rebreathing (Siebenmann et
al., 2015), doppler echocardiography (Bogui et al., 2013), pulse contour analysis
(Siebenmann et al., 2015), and impedance cardiography (Kubicek et al., 1966; Sramek,
1982; Bernstein, 1986; Charloux et al., 2000).
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CO2 rebreathing requires the subject to inhale a known concentration of CO2 to
create equilibrium with the lungs. At which point, a pulse oximeter or arterial blood sample
can be used to determine the concentration of arterial O2. By using the Fick Equation, CO
can be estimated (Faulkner et al., 1971).
Acetylene rebreathing requires a known mixture of gas to be inhaled by the
subjects. Three breaths are required to achieve equilibrium between the gas supply and the
lungs. Inert gas rebreathing follows a similar concept where the inert gas diffused into the
blood, but does not bind with hemoglobin. The rate at which the concentrations of gas
decreases from the source is proportional to CO (Bell et al., 2003; Siebenmann et al., 2015).
Doppler echocardiography uses sound waves and ultrasound imaging to measure
left ventricle cross-sectional area. SV per cardiac cycle is estimated to be the difference in
cross-sectional measurements between EDV and ESV (Bogui et al., 2013).
Pulse contour analysis measures SV using a fingertip clamp to analyze the arterial
impedance per pulse beat. The changes in pulse systolic area is used to estimate CO.
Although this method is considered non-invasive, thermodilution is used to calibrate the
device (Siebenmann et al., 2015).
Impedance cardiography (ICG) is a similar concept to pulse contour analysis.
However, the impedance is measured in the thoracic region, and the calibration process
does not entail an invasive component. ICG attempts to continually measure CO through a
noninvasive technique based off Ohm’s Law, which states that Resistance = Voltage /
ampere. Electrical current will travel the path of least resistance, so as the heart ejects blood
from the left ventricle, the current is “absorbed” by the ejected blood. The degree of
absorption is used to calculate SV.
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Hemodynamics across Treadmill and Cycle Exercise
When comparing treadmill and cycle exercise at a given HR, percent VO2 max of
the given mode is statistically higher in cycling compared to treadmill exercise (McArdle
and Magel, 1970). When comparing treadmill and cycle exercise at a given VO2, CO is
equal across modes; however, this is a result of greater SV in running compared to a higher
HR in cycling at the given intensity (Hermansen, Ekblom and Saltin, 1970). Furthermore,
at a given percent of VO2 max, mean arterial pressure (MAP) was no difference across
exercise modes (Hermansen, Ekblom and Saltin, 1970).
At maximal exercise, CO is greater in running due to a greater SV with equivalent
maximal heart rates across modes, which allows for 6-11% more oxygen uptake in
treadmill exercise

(Hermansen, Ekblom and Saltin, 1970; Faulkner et al., 1971).

Furthermore, MAP can be 10% greater in maximal cycling compared to maximal treadmill
exercise (Hermansen, Ekblom and Saltin, 1970). To compare hemodynamic measures
across exercise modes at submaximal and maximal intensities, Hermansen and Faulker
used dye dilution and CO2 rebreathing techniques, respectively.

ICG History
Nyboer (Nyboer, Kreider and Hannapel, 1950) first implemented this practice by
placing two metal strips proximally and two strips distally on the subjects’ extremities to
measure the change in blood volume. This concept was later adopted by Kubicek in the
1960s to measure stroke volume by repositioning the metal strips to the neck and around
the xiphoid region (Kubicek et al., 1966). These metal strips act as conducting and sensing
electrodes; the upper most strip on the neck and the bottom most strip on the thorax conduct
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a low amplitude, high frequency current while the bottom strip on the neck and top strip
on the thorax read the changes in volume by this equation:
𝑆𝑉 = 𝜌 ∗

𝐿2
𝑑𝑍
∗
𝑍𝑖 2 𝑑𝑡𝑚𝑎𝑥

Where  = the electrical resistivity of blood at 100kHz (which has an average value of 150
ohm-cm); L = the mean distance between the two inner electrodes in cm; Zi = the
impedance between the two inner electrodes in ohms; and dZ = the extrapolated maximum
impedance change during systole (Kubicek et al., 1966). When using Kubicek’s equation
for ICG, it must be assumed that the thorax is cyndrical in shape. In the 1980s, Sramek
critiqued Kubicek’s equation by creating a constant for blood resistivity and altering the
thoracic shape to be a truncated cone to provide more accurate measurements (Sramek,
1982):
𝑆𝑉 =

𝐶 2 𝐿𝑇 ∗ 𝑑𝑍/𝑠𝑒𝑐
37 ∗ 𝑍𝑖

Where C = the average thoracic circumference at the xiphoid processes in cm; L = the
average distance between the sensing electrodes in cm; Zi = thoracic impedance in ohms;
T = ventricular ejecting time in seconds, and dZ/sec is the maximum rate of impedance
change in ohms/sec. When impedance cardiographs are designed to use the Sramek
equation, SV values were underestimated when the individual was 15-20% overweight; as
a result, Berstein altered the equation further to enhance ICG accuracy by accounting for
the individual’s body size (Bernstein, 1986):
𝑆𝑉 = 𝛿 ∗

(0.17𝐻)3
𝑑𝑍/𝑑𝑡𝑚𝑎𝑥
∗𝑇∗
4.2
𝑍𝑖
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Where  is the weight correction factor for the individual and H is height in cm. Though
different non-invasive methods, including ICG, are available to measure stroke volume,
use of these methods compromises validity.
In recent years, a new ICG device, known as the PhysioFlow, has been developed
to continually measure hemodynamics at rest and during exercise. These hemodynamic
measures include CO, cardiac index (CI), SV, stroke volume index (SVi), ventricular
ejection time (VET), estimated ejection fraction (EF), estimated end diastolic volume
(EDV), and systemic vascular resistance (SVR) (Charloux et al., 2000). CI and SVi are
measures of CO and SV, respectively, that are normalized to the body surface area (BSA)
of an individual.
The PhysioFlow uses six electrodes: two above the supraclavicular fossa, two level
with the xiphoid processes left of the spine, and two ECG electrodes located at V1 and V6
(Charloux et al., 2000). Unlike previous ICG devices, the electrodes placed on xiphoid
processes can vary, and the recorded values will retain similar values (r=0.995) (Tan, Lai
and Hwang, 2006).
The formula that calculates the hemodynamics slightly differs from previous ICG
devices (Charloux et al., 2000):
𝐶𝑂 = 𝑓𝑐 ∗ 𝑆𝑉𝑖 ∗ 𝐵𝑆𝐴
Where fc is the heart rate of the subject in beats per minute calculated off the R-R interval
of the ECG leads. Body mass and height are entered into the device, allowing the
PhysioFlow to calculate BSA. The high frequency of 75kHz and low amplitude of 1.8mA
is able to calculate the amount of blood ejected per cardiac cycle. Knowing the volume of
blood pumped per beat in relation to the individual’s body surface area allows for the
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PhysioFlow to calculate CO and SV. Greater details describing the algorithms used by the
PhysioFlow have been described previously (Charloux et al., 2000).

ICG Validity
Several studies have validated the PhysioFlow’s measurements against the direct
Fick Method (Richard et al., 2001; Tordi et al., 2004) and CO2 rebreathing (Tordi et al.,
2004), and dye-dilution (Robach et al., 2008) in healthy (Richard et al., 2001; Tordi et al.,
2004; Robach et al., 2008) as well as clinical populations (Charloux et al., 2000; Ferreira
et al., 2012). In some cases, the PhysioFlow’s measurements can over-estimate when
compared to the direct Fick Method (Bougault, 2005; Siebenmann et al., 2015), inert gas
rebreathing (Siebenmann et al., 2015), and pulse contour analysis (Siebenmann et al.,
2015). On the other hand, the PhysioFlow’s measurements have been underestimated
when compared to single breath acetylene uptake method (Wang et al., 2014).
Researchers may opt to use the PhysioFlow due to the additional variables, other
than CO, that can be recorded. The algorithm that the PhysioFlow uses calculates additional
variables, such as left cardiac work index (LCWi), early diastolic filling ratio (EDFR),
contractility index (CTi), and systemic vascular resistance index (SVRi). LCWi is the
amount of work the left ventricle must produce to eject blood in relation to the individual’s
BSA. EDFR is the ratio of peak left ventricle filling between early and late diastole. CTi is
the heart’s force production, independent of preload and afterload. SVRi is the afterload of
a cardiac cycle in relation to BSA. These variables are continuously recorded through the
duration of exercise. Having the capability to analyze multiple variables with a single
device can save time, money, and effort of staff in a given setting.
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Purpose
To date, no study has assessed the physiological differences across treadmill and
cycle exercise using PhysioFlow ICG. Therefore, the purpose of the present study is to
investigate whether hemodynamic measures assessed via PhysioFlow impedance
cardiography are consistent within and across running and cycling exercise tests at two
absolute submaximal intensities. It is hypothesized that the PhysioFlow impedance
cardiography measures within an exercise mode will be high (ICC 0.7). However, it is
hypothesized that SV during running will be higher compared to cycling.
Assumptions
It is assumed that all subjects followed pre-test instructions of fasting and
abstaining from caffeine and alcohol four hours prior to testing as well as refrained from
strenuous exercise 24 hours prior to testing. It must be assumed that the ACSM metabolic
equations are accurate as the cycling protocol will be tailored to each subject due to
differences in body weight from subject to subject.
Limitations
The sample of subjects in this study was not completely random as subjects were
recruited through word-of-mouth recruiting and bulk-email requests advertising the need
for subjects. The present study cannot validate the PhysioFlow due to lack of access to
direct measurements, so the present study must rely on previous research to validate the
device.
Delimitations
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Delimitations of this study include the use of healthy male subjects, 18 years and
older. Female hemodynamics vary throughout the different stages of the menstrual cycle
causing variation that is difficult to control. Studies were performed at the same time of
day to eliminate diurnal variation in hemodynamics within subjects.
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Chapter 2
Methodology
Subjects
Twenty-one (n=21) male subjects, who were all apparently healthy with no
previous diagnosis of cardiovascular, pulmonary, or metabolic disease were recruited from
the James Madison University campus. Females were not recruited due to hormonal
changes in the menstrual cycle that could lead to decreased systemic vascular resistance
altering hemodynamics (Chapman et al., 1997). Individuals who could not participate in
vigorous exercise due to orthopedic limitations were also excluded from the study. All
experimental protocols were approved by the Institutional Review Board for Human
Subject Research at James Madison University prior to testing. All subjects completed the
informed consent prior to participation.

Pre-test
Subjects were asked to visit JMU’s Human Performance Lab on four separate
occasions for approximately 1 hour each visit. Subjects were fasted and abstained from
caffeine and alcohol for four hours prior to testing. Subjects were given two questionnaires
to complete: the Physical Activity Readiness Questionnaire (PARQ) and the International
Physical Activity Questionnaire, Short Form (IPAQ). The PARQ was completed to ensure
subjects were cleared for exercise. IPAQ was administered to obtain self-reported physical
activity levels. Subject height and weight were recorded to the nearest 0.5cm and 0.1kg,
respectively.
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Hemodynamic Measures
Hemodynamic variables were measured using the PhysioFlow (PF07 Enduro,
Manatec Biomedical; Paris, France). Primary hemodynamic variables included CO, HR,
and SV. Secondary variables consisted of end diastolic volume (EDV), ejection fraction
(EF), systemic vascular resistance (SVR), contractility index (CTi), and left cardiac work
index (LCWi). Six electrodes were used for this device: two electrodes placed above the
supraclavicular fossa, two placed just left of the spine dorsally in line with the xiphoid
processes, and two ECG electrodes (V1 and V6). Prior to electrode placement, each site
was shaved to remove body hair, alcohol pads then cleaned the site, and lastly skin prep
gel was applied in the specific area to lower impedance and improve signal quality. After
electrodes were placed in the proper sites, subjects laid in the supine position for resting
blood pressure measurements in accordance with the ACSM guidelines (American College
of Sports Medicine, 2013). Thereafter, the PhysioFlow was auto-calibrated after 30 heart
cycles. Blood pressure was measured a second time in the position of exercise (i.e. standing
or sitting on cycle ergometer) prior to testing. The PhysioFlow recorded hemodynamic
measures in 10 second averages at rest and throughout the exercise test in addition to a 3minute recovery period.

Exercise Tests
Subjects performed a total of four graded exercise tests, two on a treadmill (TM1
and TM2) and two on an electronically braked cycle ergometer (CYC1 and CYC2).
Oxygen consumption was measured through indirect calorimetry via a metabolic cart
(Parvo Medics TrueOne 2400; Sandy, UT). TM1 was designated as the first visit while the
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final three tests were conducted in a randomized order. All four tests were completed with
a minimum of 48 hours between tests and occurred at the same time of day for each subject.
The custom treadmill protocol was established as follows: 2.6mph @ 0% (1min), 3.1mph
@ 1.5% (1min), 3.6mph @ 2.5% (5 min), 4mph @ 3.5% (1 min), 4mph @ 5.5% (5min),
5mph @ 1% (1min), 5.3mph @ 2.5% (1min), 5.6mph @ 5% (1min), 6.1mph @ 6.5%
(1min), 6mph @ 10.5% (1min), 6mph @ 14% (1min), 6mph @ 16.5%, 6.2mph @ 17.5%,
and 6.4mph @ 18.5% (if reached, until exhaustion).
The cycling test protocol will be as follows: 2 METs (1 min), 3.4 METs (1 min), 5
METs (5 min), 6.4 METs (1 min), 7 METs (5 min), 8.4 METs (1 min), 9.8 METs (1 min),
11.2 METs (1 min), 12.6 METs (1 min), 14 METs (1 min), 15.4 METs (1 min), and 16.8
METs (if reached, until fatigue). Watts for the given METs will be estimated using the
metabolic equations (American College of Sports Medicine, 2013).
Subjects exercised to volitional exhaustion, an inability to maintain 60 revolutions
per minute on the cycle ergometer, or if the subject reported any adverse effects as outlined
in the ACSM Guidelines (American College of Sports Medicine, 2013). The two 5-minute
stages corresponded to moderate and vigorous exercise (MODex and VIGex) with targeted
intensities of 5 and 7 METs, respectively (American College of Sports Medicine, 2013).
CYC1 and CYC2 MET levels for a give stage were estimated using the metabolic equations
(American College of Sports Medicine, 2013). Blood pressure was measured 3 minutes
into the steady-state stages. PhysioFlow data during the final 2 minutes of MODex and
VIGex stages were averaged together to examine the PhysioFlow’s test re-test reliability.
Cycling watt intensity for MODex and VIGex were estimated from TM1’s
averaged VO2 at the respective stage. These estimations were confirmed with VO2
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measurements during the cycling tests. If the subject did not achieve the desired VO2 value
within 2 minutes of the MODex and VIGex stages, watts were adjusted accordingly to
mimic TM1 VO2 values at the respective stages. This was done to ensure VO2 was equal
across treadmill and cycle exercise for the respective stages.

Statistical Analyses
Two-way ANOVAs with a Bonferroni correction were used to determine main
effects for trial and intensity within an exercise mode. For across mode analysis, a twoway ANOVA with Bonferroni correction was used to determine main effects for mode and
intensity for the averages of the TM trials and the averages of the CYC trials. Intraclass
correlation coefficients (ICC) determined the agreement within and across exercise modes
at the absolute submaximal intensities. Coefficients of variation (CV) were used to
determine the variability within and across exercise trials. Statistical significance was set
a priori at p<0.05.
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Abstract
Impedance cardiography (IC) measures cardiovascular hemodynamics noninvasively during exercise. However, IC measurements assessing physiological differences
across treadmill (TM) and cycle (CYC) exercise has not been investigated. The purpose
of this study is to investigate whether hemodynamic measurements assessed via IC are
consistent between TM and CYC exercise at two absolute exercise intensities. Twenty-one
men (age = 21.4  0.5 y; BMI = 24.4  0.5) completed four exercise tests, two TM and two
CYC. Within each test, two, five-minute, steady-state stages were completed with targeted
intensities of 5 (MODex) and 7 (VIGex) metabolic equivalents (METs). Oxygen
consumption (VO2) was measured by indirect calorimetry. Hemodynamic measures were
obtained via IC (PhysioFlow, PF07 Enduro) and included cardiac output (CO), heart rate
(HR), stroke volume (SV), end diastolic volume (EDV), ejection fraction (EF), systemic
vascular resistance (SVR), contractility index (CTi), and left cardiac work index (LCWi).
Within treadmill exercise, there were no main effects for trial, except for HR. There were
no main effects for trial within CYC exercise. Across exercise modes, there were no
significant differences between TM and CYC exercise for all variables, with the exception
of higher HR in CYC, and higher SV and EDV in TM. ICCs were strong for all variables
except VIGex SVR and VIGex LCWi. IC hemodynamic measurements showed strong
repeatability across modes for all hemodynamic variables during MODex. For VIGex, all
variables showed strong correlations, except for SVR and LCWi. Lack of agreement may
be associated with daily variation in hemodynamics or physiological differences across
modes with the remainder of discrepancies associated with device error.
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Introduction
In cardiovascular physiology, cardiac output (CO) is the product of stroke volume
(SV) and heart rate (HR) and is a central limiting factor in an individual’s maximal oxygen
consumption (VO2 max) (American College of Sports Medicine and Ehrman, 2014).
Resting SV ranges from 60-100mL/beat, with body size and training status being the most
influential factors (American College of Sports Medicine and Ehrman, 2014). While
exercising, a HR of 120 beats per minute (bpm) is typically the threshold of SV plateau at
120mL/beat; however, endurance trained athletes may achieve values as high as
200mL/beat with no plateau through maximal exercise (Gledhill, Cox and Jamnik, 1994).
Additionally, exercise mode can influence CO dynamics. At a given VO 2, CO is equal
between treadmill and cycling; however, this is a result of higher SV in running compared
to a higher HR in cycling at the given intensity (Hermansen, Ekblom and Saltin, 1970). At
maximal exercise, CO is greater in running due to a greater SV with equivalent maximal
heart rates across modes (Hermansen, Ekblom and Saltin, 1970; Faulkner et al., 1971).
There are several methods used to determine CO. The direct Fick method and dye
dilution have been considered the “gold standard” methods (Warburton et al., 1999).
Though these techniques are considered the most valid, their invasive nature can become
difficult and risky during exercise due to catheters inserted in or near the heart (Warburton
et al., 1999). This issue led to the development of several non-invasive methods, including
carbon dioxide (CO2) rebreathing, acetylene rebreathing, inert gas rebreathing, Doppler
echocardiography, pulse contour analysis, and impedance cardiography (ICG). Of these,
ICG is the only non-invasive technique allowing for continual recording of hemodynamics.
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ICG is based off Ohm’s Law with the concept first introduced by Nyboer (Nyboer,
Kreider and Hannapel, 1950) and later developed by Kubicek (Kubicek et al., 1966) to
measure thoracic impedance. Sramek (Sramek, 1982) and Bernstein (Bernstein, 1986)
refined the technique further, accounting for thoracic volume and body size, respectively.
Most recently, an ICG device, known as the PhysioFlow, has been developed to
continually measure hemodynamics at rest and during exercise and has been validated
against the direct Fick method (Charloux et al., 2000; Richard et al., 2001) and dye dilution
(Robach et al., 2008). To date, no study has tested the physiological differences across
exercise modes at absolute submaximal intensities using PhysioFlow ICG. Therefore, the
purpose of the present study was to investigate whether hemodynamic measures assessed
via PhysioFlow impedance cardiography were consistent across running and cycling
exercise tests at two absolute submaximal intensities. It was hypothesized that the
PhysioFlow impedance cardiography measures within an exercise mode will be
reproducible (ICC 0.7). However, it was hypothesized that stroke volume during running
will be higher compared to cycling.
Methods

Subjects
Twenty-one (n=21) male subjects, who were all apparently healthy with no
previous diagnosis of cardiovascular, pulmonary, or metabolic disease were recruited from
the James Madison University campus. Females were not recruited due to hormonal
changes in the menstrual cycle that could lead to decreased systemic vascular resistance
altering hemodynamics (Chapman et al., 1997). Individuals who could not participate in
vigorous exercise due to orthopedic limitations were also excluded from the study. All
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experimental protocols were approved by the Institutional Review Board for Human
Subject Research at James Madison University prior to testing. All subjects completed the
informed consent prior to participation.

Pre-test
Subjects were asked to visit JMU’s Human Performance Lab on four separate
occasions for approximately 1 hour each visit. Subjects were fasted and abstained from
caffeine and alcohol for four hours prior to testing. Subjects were given two questionnaires
to complete: the Physical Activity Readiness Questionnaire (PARQ) and the International
Physical Activity Questionnaire, Short Form (IPAQ). The PARQ was completed to ensure
subjects were cleared for exercise. IPAQ was administered to obtain self-reported physical
activity levels. Subject height and weight were recorded to the nearest 0.5cm and 0.1kg,
respectively.

Hemodynamic Measures
Hemodynamic variables were measured using the PhysioFlow (PF07 Enduro,
Manatec Biomedical; Paris, France). Primary hemodynamic variables included CO, HR,
and SV. Secondary variables consisted of end diastolic volume (EDV), ejection fraction
(EF), systemic vascular resistance (SVR), contractility index (CTi), and left cardiac work
index (LCWi). The six electrodes were used for the device and placed in identical fashion
to previous literature (Charloux et al., 2000). Then subjects laid in the supine position for
resting blood pressure measurements in accordance with the ACSM guidelines (American
College of Sports Medicine, 2013). Thereafter, the PhysioFlow was auto-calibrated after
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30 heart cycles. Blood pressure was measured a second time in the position of exercise (i.e.
standing or sitting on cycle ergometer) prior to testing. The PhysioFlow recorded
hemodynamic measures in 10 second averages at rest and throughout the exercise test in
addition to a 3-minute recovery period.

Exercise Tests
Subjects performed a total of four graded exercise tests, two on a treadmill (TM1
and TM2) and two on an electronically braked cycle ergometer (CYC1 and CYC2).
Oxygen consumption was measured through indirect calorimetry via a metabolic cart
(Parvo Medics TrueOne 2400; Sandy, UT). TM1 was designated as the first visit while the
final three tests were conducted in a randomized order. All four tests were completed with
a minimum of 48 hours between tests and occurred at the same time of day for each subject.
The custom treadmill and cycle protocols can be seen in Table 1.
Subjects exercised to volitional exhaustion, an inability to maintain 60 revolutions
per minute on the cycle ergometer, or if the subject reported any adverse effects as outlined
in the ACSM Guidelines (American College of Sports Medicine, 2013). The two 5-minute
stages corresponded to moderate and vigorous exercise (MODex and VIGex) with targeted
intensities of 5 and 7 METs, respectively (American College of Sports Medicine, 2013).
CYC1 and CYC2 MET levels for a give stage were estimated using the metabolic equations
(American College of Sports Medicine, 2013). Blood pressure was measured 3 minutes
into the steady-state stages. PhysioFlow data during the final 2 minutes of MODex and
VIGex stages were averaged together for data analysis.
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Cycling watt intensity for MODex and VIGex were estimated from TM1’s
averaged VO2 at the respective stage. These estimations were confirmed with VO2
measurements during the cycling tests. If the subject did not achieve the desired VO2 value
within 2 minutes of the MODex and VIGex stages, watts were adjusted accordingly to
mimic TM1 VO2 values at the respective stages. This was done to ensure VO2 was equal
across treadmill and cycle exercise for the respective stages.

Statistical Analyses
Two-way ANOVAs with a Bonferroni correction were used to determine main
effects for trial and intensity within an exercise mode. For across mode analysis, a twoway ANOVA with Bonferroni correction was used to determine main effects for mode and
intensity for the averages of the TM trials and the averages of the CYC trials. Intraclass
correlation coefficients (ICC) determined the agreement within and across exercise modes
at the absolute submaximal intensities. Coefficients of variation (CV) were used to
determine the variability within and across exercise trials. Statistical significance was set
a priori at p<0.05.

Results
Subjects characteristics are listed in Table 2. Hemodynamic averages are displayed
in Tables 3 and 4 for primary and secondary variables, respectively. For the treadmill, there
were no main effects for trial for hemodynamic variables, with the exception of HR. For
cycle exercise, there were no main effects for trial for any hemodynamic variable.
Within treadmill exercise, ICC for primary and secondary hemodynamic variables
displayed reliability coefficients of r ≥ 0.7 at both intensities indicating good agreement.
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For MODex and VIGex, CVs ranged from 3.4-8.7% and 3.1-10.5%, respectively. Within
MODex of cycle, all correlation coefficients achieved r ≥ 0.7, indicating strong agreement,
with the exception of SVR (r = 0.68) and CTi (r = 0.47) with CVs ranging from 2.3-12.1%.
For VIGex cycling, all hemodynamic variables had correlation coefficients r <0.7, except
for VO2 (r = 0.93) and HR (r = 0.85) indicating good agreement for the two primary
variables. For VIGex cycling, CVs ranged from 3.5-15.1%.
For across mode analyses, the average values of TM1 and TM2 were compared to
the averages of CYC1 and CYC2. Across treadmill and cycle exercise, there was an
interaction effect for trial by intensity for CTi but not for other variables. There were no
main effects for trial for any hemodynamic variable, with the exception of greater HR in
cycling and greater SV and EDV in treadmill exercise.
Across treadmill and cycle exercise all primary and secondary variables during
MODex had reliability coefficients r ≥ 0.7. For VIGex, CO, HR, SV, EDV, EF, and CTi
exhibited reliability coefficients r ≥ 0.7, indicating strong agreement. However, SVR and
LCWi achieved reliability coefficients of r < 0.7 showing a lack of agreement across
treadmill and cycle exercise. CVs ranged from 2.7-9.3% and 2.1-10.5% for MODex and
VIGex, respectively across exercise modes.
Discussion
The purpose of this study was to determine the physiological differences across
treadmill and cycle exercise utilizing PhysioFlow ICG at moderate and vigorous exercise
intensities. The present study found strong agreement within treadmill exercise and
moderate cycle exercise. Furthermore, PhysioFlow ICG showed strong agreement for the
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majority of primary and secondary hemodynamic variables for both intensities when
comparing across treadmill and cycle exercise.
The current study is the first to examine the reliability of PhysioFlow ICG within
treadmill exercise. For MODex and VIGex intensities, all primary and secondary
hemodynamic variables were in strong agreement. There were no main effects for trials
within treadmill exercise with the exception of HR. For a given stage, HR decreased by 4
bpm from TM1 to TM2. Sime et. al. discovered that HR statistically decreased in
subsequent testing in about one-third of subjects with one week of separation between trials
possibly due to task and setting familiarity (Sime et al., 1972). As there was no
familiarization trial performed in the current study, this phenomenon could have occurred
as TM1 was designated as the first visit.
Previous literature has investigated the PhysioFlow ICG’s reproducibility in cycle
exercise. Schultz et. al. determined the reliability during submaximal cycle exercise at 70%
of age predicted max heart rate (APMHR) during a 5-minute steady state bout (Schultz et
al., 2012). Hemodynamic data was recorded for 5 minutes once steady state was achieved
at the given workload. Schultz observed all ICC’s for hemodynamic variables achieving r
≥ 0.7 during all exercise stages. Schultz’s 70% APMHR best corresponds with the current
study’s MODex as both are considered moderate intensities (American College of Sports
Medicine, 2013). The present study’s MODex showed similar results to Schultz et. al. 70%
APMHR with all ICC achieve r ≥ 0.7, with the exception of SVR (r = 0.68) and CTi (0.47).
The lack of agreement in SVR is uncertain due to no statistical differences in systolic and
diastolic blood pressure (SBP and DBP). However, the lack of agreement in CTi may be
attributed to poor signal quality leading to device error. There were two outliers outside
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two standard deviations in MODex CTi for CYC1, and when omitted from the cycle ICC
analysis, r = 0.91 (p <0.001).
VIGex of the current study was designated to be a vigorous submaximal intensity
at an absolute workload. In contrast to treadmill exercise, cycle exercise correlation
coefficients in VIGex were r < 0.7 for all variables except for HR. The low correlations
may be attributed to the vigorous nature of the steady-state stage in an unfamiliar exercise
mode, as most subjects were not cycle trained. This could have resulted in a different
physiological response in the higher intensity stage from CYC1 to CYC2. Respiratory
exchange ratio (RER) was significantly higher in cycle exercise compared to treadmill at
the vigorous intensity (0.94 ± 0.07 versus 0.87 ± 0.04, p<0.001). The difference in RER
suggests that VIGex cycling was relatively more difficult compared to treadmill exercise
at the same VO2. In a previous study where subjects performed maximal treadmill and
cycling tests, RER was significantly higher in cycling at 150 and 170 bpm (McArdle and
Magel, 1970). Furthermore, percent VO2 max was significantly higher at 150 and 170 bpm
in cycling compared to treadmill suggesting cycle exercise was more demanding at a given
heart rate.
When comparing across modes, SV significantly increased in treadmill exercise
possibly due to a greater EDV allowing for a more efficient contraction via the FrankStarling mechanism. Contrarily in cycle exercise, there was no change in SV, EDV, EF,
and CTi with an increase in intensity. SV traditionally plateaus at 40% VO2 max (Vella
and Robergs, 2005). MODex VO2 was calculated to be 45% of cycling VO2 max for both
cycle trials suggesting the plateau in SV may result from no change in EDV, CTi, and EF
in cycle exercise. To compensate for the statistically lower SV (p = 0.01), cycling HR was
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measured to be statistically higher (p=0.01) to create an equal CO at the given VO2 across
exercise modes. Similar results were found previously while using the gold-standard, dye
dilution (Hermansen, Ekblom and Saltin, 1970). During MODex and VIGex, cycling HR
averaged to be 4 and 6 bpm higher compared to treadmill for the given stage. These values
were at the lower end of Hermansen’s 6-10 bpm difference between cycle and treadmill
exercise. Hermansen attributed the difference in hemodynamics due to increased pressure
in cycling that may impede blood flow to the muscle.
In the present study, mean arterial pressure (MAP) was not statistically different
across exercise modes at a given intensity; however, this is due to statistically higher SBP
(MODex SBP: 140 ± 11 versus 146 ± 14 mmHg, p=0.001; VIGex SBP: 158 ± 3 versus 169
± 4mmHg, p=0.002) and statistically lower DBP (MODex DBP: 67 ± 8 versus 60 ± 6
mmHg, p=0.001; VIGex DBP: 64 ± 1 versus 56 ± 1 mmHg, p = 0.002) in cycling compared
to treadmill. The higher SBP in cycle exercise can be attributed to prolonged isometric
contractions and vessel compression as a result of pedaling mechanics versus running
(Palatini, 1988). The vessel compression during cycling reduces the compliance of the
arteries causing a greater decrease in DBP (London and Guerin, 1999). As a result, HR
may be increased at a given VO2 to maintain adequate blood flow with the increased vessel
compression during cycling.
There are some physiological mechanisms that may explain the lack of agreement
across exercise modes. Previous literature has reported SVR as the product of MAP and
mean right atrial pressure (MRAP) divided by CO (Stamler et al., 1994). There were no
significant differences in MAP or CO across modes during VIGex. Therefore, the lack of
agreement in SVR may be associated with differences in MRAP. However, MRAP was
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not measured in the current study, so this cannot be concluded with certainty. Although
MAP was not statistically different during VIGex, the lack of agreement may extend from
the observed differences in SBP and DBP across exercise modes.
Similarly, LCWi is calculated as the difference between MAP and left ventricular
end diastolic pressure (LVEDP) multiplied by cardiac index (CI), which is CO accounted
for body surface area (Ferguson, Gregg and Shadle, 1954). The lack of agreement across
exercise modes could also be attributed to the observed differences in SBP and DBP.
Moreover, with EDV statistically greater in treadmill exercise, the LVEDP would have
been greater compared to cycling suggesting that the differences in pressure may lead to
the lack of agreement in VIGex LCWi across modes (Burkhoff, Mirsky and Suga, 2005).
Lastly, there was a significant mode by intensity interaction effect for CTi across
exercise modes with a trending main effect for intensity (p = 0.07). CTi is known as the
heart’s inherent ability to produce force in relation to an individual’s body surface area,
independent of changes in preload and afterload (Bombardini, 2005). However, in a recent
review by Bombardini discussing myocardial contractility, it is suggested that greater force
will be produced with an increase in sarcomere length at a given calcium ion concentration
(Bombardini, 2005). In treadmill exercise, there may be increased sarcomere length due to
greater EDV as intensity increases. As a result, contractility may be increasing more in
treadmill exercise compared to cycle as intensity increases.
Limitations
The sample of subjects in this study was not completely random as subjects were
college-aged males recruited through word-of-mouth recruiting and bulk-email requests
advertising the need for subjects. However, this can be viewed as a strength of the current
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study as using a homogeneous population would likely reduce the hemodynamic variable
ICCs.
The present study cannot validate PhysioFlow ICG due to lack of access to direct
measurements, so the present study must rely on previous research to validate the device
(Charloux et al., 2000; Richard et al., 2001; Robach et al., 2008). It is important to note
that lack of agreement may reflect physiological differences across exercise modes, as well
as day-to-day variation in hemodynamics with the remainder of variability associated with
the device.
Future research may wish to investigate PhysioFlow ICG measures in subjects who
are trained in running and cycling exercise, such as duathlon participants or triathletes. This
may establish better agreement across modes or in VIGex of cycling. Experimenting across
broader range of exercise modes would be beneficial to determine if different postural
positions effect hemodynamics during exercise. Furthermore, future research may wish to
utilize invasive methods to validate the hemodynamic differences observed between TM
and CYC.
Conclusions
Across treadmill and cycle exercise, the PhysioFlow ICG showed higher HR with
lower SV and EDV in cycling exercise for a given VO2, which is in accordance with
previous literature using a gold standard technique. Correlation coefficients were strong
across exercise mode during MODex for all hemodynamic variables. For VIGex, all
hemodynamic variables were strong with the exception of SVR and LWCi. However, the
lack of agreement may be explained by the physiological differences observed across
exercise mode. Finally, device error should be associated with the lack in agreement after
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day-to-day variation in hemodynamics and physiological differences across exercise
modes are taken into consideration.
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Table 1 Treadmill and Cycling Protocols
Time

TM Speed (mph)

TM Grade (%)

Cycle METs

0:01 - 0:59
2.6
0
2
1:00 - 1:59
3.1
1.5
3.4
2:00 - 6:59*
3.6
2.5
5
7:00 -7:59
4
3.5
6.4
8:00 - 12:59*
4
5.5
7
13:00 – 13:59
4.6
0
8.4
14:00-14:59
5
1
9.8
15:00 – 15:59
5.3
2.5
11.2
16:00 – 16:59
5.6
5
12.6
17:00 – 17:59
6.1
6.5
14
18:00 – 18:59
6
10.5
15.4
19:00-19:59
6
14
16.8
20:00-20:59
6
16.5
18.2
21:00-21:59
6.2
17.5
19.6
22:00-22:59
6.4
18.5
21
*Data collected in final two minutes of the given stage was used for analyses.
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Table 2 Subject Characteristics (n=21)
Age (years)
IPAQ (METminweek-1)

21.4  0.5
4825.7  801.1

Height (cm)

178.9  2.0

Weight (kg)

73.2  2.7

BMI (kg/m2)

24.5  0.5

VO2 max (mLkg-1min-1)

51.5  1.5

Mean (SD) cm: IPAQ: International Physical Activity Questionnaire. MET:
metabolic equivalent of task. BMI: body mass index. VO2 max: maximal oxygen
consumption.
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Table 3 Mean Values of Primary Hemodynamic Variables for Treadmill and Cycle
exercise at moderate and vigorous intensity.

MODex VO2
(mLmin-1)
VIGex VO2
(mLmin-1)
MODex CO
(Lmin-1)
VIGex CO
(Lmin-1)
MODex HR
(beatsmin-1)
VIGex HR*
(beatsmin-1)
MODex SV
(mLbeat-1)
VIGex SV*
(mLbeat-1)

Averaged TM

Averaged CYC

1571.5  253.6

1565.0  260.4

2248.6  391.9†

2326.2  432.8†

14.3  1.9

14.2  2.9

19.6  2.9†

18.8  2.6†

114  11

118  13

145  14†

151  17†

126.5  16.8

121.3  22.1

134.5  18.0†

124.6  14.3

Mean (SD). * indicates a significant (p <0.05) main effect for mode of across treadmill (TM) and cycle
(CYC) exercise. † indicates significant (p <0.05) main effect for intensity within a mode. MODex:
moderate exercise. VIGex: vigorous exercise. VO2: oxygen consumption. CO: cardiac output. HR: heart
rate. SV: stroke volume.
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Table 4 Mean Values of Secondary Hemodynamic Variables for Treadmill and Cycle
exercise at moderate and vigorous intensity.
Averaged TM
MODex EDV
(mL)
VIGex EDV*
(mL)
MODex EF
(%)
VIGex EF
(%)

Averaged CYC

155.2  23.7

145.7  26.8

161.8  25.2†

150.4  25.4

82.3  5.2

83.6  6.4

83.8  6.8

83.4  7.1

MODex SVR
(dynscm-5)
VIGex SVR
(dynscm-5)

516.1  73.8

503.7  72.7

396.8  66.6†

400.0  53.1†

MODex CTi

350.7  67.9

369.0  98.3

VIGex CTi

400.4  88.6†

369.2  84.3

9.1  1.3

8.7  2.0

12.9  2.0†

12.0  1.8†

MODex LCWi
(kgmm2-1)
VIGex LCWi
(kgmm2-1)

Mean (SD). * indicates a significant (p <0.05) main effect for mode of across treadmill (TM) and cycle
(CYC) exercise. † indicates significant (p <0.05) main effect for intensity within a mode. MODex:
moderate exercise. VIGex: vigorous exercise. EDV: end diastolic volume. EF: ejection fraction. SVR:
systemic vascular resistance. CTi: contractility index. LCWi: left cardiac work index.
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160

*†

HR (beatsmin-1)

150
140
130
120
110

Treadmill
Cycle

100
Moderate exercise

Vigorous exercise

Figure 1 Heart rate response from moderate to vigorous exercise across treadmill and
cycle exercise. * indicating significant (p <0.05) main effect for mode. † indicating
significant (p <0.05) main effect for intensity.
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145.00

*†

140.00

SV (mLbeat-1)

135.00
130.00
125.00
120.00
115.00
Treadmill

110.00

Cycle
105.00
Moderate exercise

Vigorous exercise

Figure 2 Stroke Volume response from moderate to vigorous exercise across treadmill
and cycle exercise. * indicating significant (p <0.05) main effect for mode. † indicating
significant (p <0.05) main effect for intensity.
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170.00

*†

165.00

EDV (mL)

160.00
155.00
150.00
145.00
140.00
135.00
Treadmill
130.00
Cycle
125.00
Moderate exercise

Vigorous exercise

Figure 3 End Diastolic Volume response from moderate to vigorous exercise across
treadmill and cycle exercise. * indicating significant (p <0.05) main effect for mode. †
indicating significant (p <0.05) main effect for intensity.
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430.00
410.00

CTi

390.00
370.00
350.00
330.00
Cycle

310.00

Treadmill

290.00
Moderate exercise

Vigorous exercise

Figure 4 Contractility Index response from moderate to vigorous exercise across treadmill
and cycle exercise. * indicating significant (p <0.05) main effect for mode. † indicating
significant (p <0.05) main effect for intensity.
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Appendices
James Madison University
Department of Kinesiology
Informed Consent
Purpose
You are being asked to volunteer for a research study conducted by Dr. Trent Hargens
from James Madison University entitled, “Reliability of Impedance Cardiography in the
Measurement of Cardiovascular Hemodynamics During Exercise”.
The goal of this study is to examine whether a method for non-invasively measuring
cardiovascular measures is repeatable on multiple days and on multiple exercise modes.
Experimental Procedures
You will be asked to visit the Human Performance Laboratory (HPL) in Godwin Hall 4
times over the course of about 2 – 4 weeks. Your total time commitment for
participation in this study will be about 4 hours (each visit about an hour).
Upon completion of this informed consent, you will be asked to complete 2 short
questionnaires, 1 that asks about your ability to participate in physical activity, and 1
that asks about your current level of physical activity participation. Each of these
questionnaires should take about 5 minutes to complete.
You will then have your height and weight measured. Upon completion of this, you will
be asked to complete a maximal treadmill exercise test. During the test, researchers will
monitor your heart rate, blood pressure and your perceived exertion to the workload
you will be doing. You will have several electrode patches placed on your skin on your
torso, back and neck. These will be connected to the device measuring the variables we
are interested in studying. During the test, you will breathe only through a mouthpiece,
with your nose clamped off, so that we can measure the amount of oxygen you use
during exercise. The treadmill will start with a very slow speed and little grade, and will
steadily increase in speed and grade throughout the test, so it will start easy, and
become very intense. At the end of the test, it should be a best effort on your part. It
may be as hard as any exercise you remember doing. The exercise test will last about 10
– 15 minutes. Prior to your arrival to the HPL that day, you will be asked to refrain from
eating for 4 hours prior to your arrival, and to avoid caffeine and alcohol for that time
period as well.
Upon completion of this visit, you will be asked to return to the HPL 3 subsequent times,
a minimum of 48 hours later, and at the same time of day as the first visit. The
remaining 3 visits will consist of an additional maximal treadmill test, identical to your

40
visit 1, or a maximal cycle exercise test. For the cycle test, you will be asked to pedal a
cycle ergometer at a certain work rate that will steadily increase in difficulty until you
are no longer able to maintain at least 50 rpm. It will start fairly easy, and become very
intense, in a similar fashion to the treadmill. We will measure the same things during
the cycle test as we do during the treadmill test. What type of test you complete
(treadmill or cycle) for visits 2 – 4 will be randomized.

Risks
There is a risk of abnormal changes during the maximal exercise tests. These changes
may include abnormal blood pressure, fainting, heart rhythm disorders, stroke, heart
attack, and death. The chance of serious heart problems during maximal exercise
among adults is very small (less than 1/10,000 maximal exercise tests). Every effort will
be made to minimize risks of an abnormal response by reviewing you health history and
providing adequate supervision of the exercise test. All staff are certified by the
American Heart Association in BLS (Basic Life Support), and all tests will be supervised by
individuals certified by the American College of Sports Medicine.
Benefits
Participation may include knowledge about your health status. You will receive
information on your cardiovascular fitness.
Inquiries
If you have any questions or concerns or you would like to receive a copy of the final
aggregate results of this study, please contact Dr. Trent Hargens at hargenta@jmu.edu
or (540) 568-5844.
Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu
Confidentiality
All data and results will be kept confidential. You will be assigned an identification
number and a pseudonym in place of your real name. At no time will your name be
identified with your individual data. The researcher retains the right to use and publish
non-identifiable data. All paper data will be kept secured in a locked cabinet in a locked
office. All electronic data will be kept on a password-protected computer in encrypted
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file folders. Upon completion of the study, only de-identified data will be kept for
research dissemination purposes, and will be kept indefinitely. All material containing
identifiable information will be destroyed. Final aggregate results will be made available
to participants upon request.
Freedom of Consent
Your participation is entirely voluntary. You are free to choose not to participate.
Should you choose to participate, you can withdraw at any time without consequences
of any kind.
I have read this consent form and I understand what is being requested of me as a
participant in this study. I freely consent to participate. I have been given satisfactory
answers to my questions. The investigator provided me with a copy of this form I
requested it. I certify that I am at least 18 years of age. By clicking "Yes" to the question
below and submitting this confidential online survey, I am consenting to participate in
this research.
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PAR-Q & YOU
(A questionnaire for People Aged 15-69)
Regular physical activity is fun and healthy, and increasingly more people are starting to become more active every day. Being more
active is very safe for most people. However, some people should check with your doctor before you start.
If you are planning to become much more physically active than you are now, start by answering the seven questions in the box
below. If you are between the ages of 15 and 69, the PAR-Q will tell you if you should check with your doctor before you start. If you
are over 69 years of age, and you are not used to being very active, check with your doctor.
Common sense is your best guide when you answer these questions. Please read the questions carefully and answer each one
honestly: check YES or NO

YES

NO

1. Has your doctor ever said that you have a heart condition and that you should only do physical activity recommended
by a doctor?

YES

NO

2. Do you feel pain in your chest when you do physical activity?

YES

NO

3. In the past month, have you had chest pain when you were not doing physical activity?

YES

NO

4. Do you lose your balance because of dizziness or do you ever lose consciousness?

YES

NO

5. Do you have a bone or joint problem (for example, back, knee or hip) that could be made worse by a change in your
physical activity?

YES

NO

6. Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart condition?

YES

NO

7. Do you have a diabetes or thyroid condition?

YES

NO

8. Do you know of any other reason why you should not do physical activity?

If
you

YES to one or more questions
A medical clearance form is required of all participants who answer ‘yes’ to any of the eight PAR-Q questions.
Note: Personal training staff reserve the right to require medical clearance from any client they feel may be at risk.

•

answered
“Yes”:

•

Discuss with your personal doctor any conditions that may affect your exercise program.
All precautions must be documented on the medical clearance form by your personal doctor.

NO to all questions
If you answered NO honestly to all PAR-Q questions, you
can be reasonably sure that you can:
start becoming much more physically active •
begin slowly and build up gradually. This is the
safest and easiest way to go.
take part in a fitness appraisal - this is an
•
excellent way to determine your basic fitness so
that you can plan the best way for you to live
actively. It is also highly recommended that you
have your blood pressure evaluated. If your
reading is over 144/94, talk with your doctor
before you start becoming much more physically
active.

DELAY BECOMING MUCH MORE ACTIVE:
If you are not feeling well because of a
•
temporary illness such a cold or a fever wait until you feel better; or
If you are or may be pregnant - talk to your
•
doctor before you start becoming more
active.
PLEASE NOTE: If your health changes so that you
then answer YES to any of the above questions, tell
your fitness or health professionals.
Ask whether you should change your physical activity
plan.

Informed Use of the PAR-Q: The Canadian Society for Exercise Physiology, Health Canada, and their agents assume no liability to persons who undertake physical
activity, and if in doubt after completing this questionnaire, consult your doctor prior to physical activity.
NOTE: If the PAR-Q is being given to a person before he or she participates in a physical activity program or a fitness appraisal, this section may be used for legal or
administrative purposes.
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“I have read, understood and completed this questionnaire. Any questions I had were answered to my full satisfaction.”

NAME__________________________________________________________________

SIGNATURE_____________________________________________________________DATE_________________________________________
___________

SIGNATURE OF PARENT or GUARDIAN____________________________________________________________________
WITNESS____________________________________________________

Note: This physical activity clearance is valid for a maximum of 12 months from the date it is
completed and becomes invalid if your condition changes so that you would answer YES to any
of the seven questions.
Supported by:
Activity Readiness Questionnaire – PAR-Q

Physical
(revised 2006
by CW)
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE
We are interested in finding out about the kinds of physical activities that people do as
part of their everyday lives. The questions will ask you about the time you spent being
physically active in the last 7 days. Please answer each question even if you do not
consider yourself to be an active person. Please think about the activities you do at
work, as part of your house and yard work, to get from place to place, and in your spare
time for recreation, exercise or sport.
Think about all the vigorous activities that you did in the last 7 days. Vigorous physical
activities refer to activities that take hard physical effort and make you breathe much
harder than normal. Think only about those physical activities that you did for at least
10 minutes at a time.
1.

During the last 7 days, on how many days did you do vigorous physical activities
like heavy lifting, digging, aerobics, or fast bicycling?
_____ days per week
No vigorous physical activities

2.

Skip to question 3

How much time did you usually spend doing vigorous physical activities on one
of those days?
_____ hours per day
_____ minutes per day

Don’t know/Not sure

Think about all the moderate activities that you did in the last 7 days. Moderate
activities refer to activities that take moderate physical effort and make you breathe
somewhat harder than normal. Think only about those physical activities that you did
for at least 10 minutes at a time.
3.

During the last 7 days, on how many days did you do moderate physical
activities like carrying light loads, bicycling at a regular pace, or doubles tennis?
Do not include walking.
_____ days per week
No moderate physical activities

Skip to question 5
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4.

How much time did you usually spend doing moderate physical activities on one
of those days?
_____ hours per day
_____ minutes per day

Don’t know/Not sure

Think about the time you spent walking in the last 7 days. This includes at work and at
home, walking to travel from place to place, and any other walking that you might do
solely for recreation, sport, exercise, or leisure.
5.

During the last 7 days, on how many days did you walk for at least 10 minutes at
a time?
_____ days per week
No walking

6.

Skip to question 7

How much time did you usually spend walking on one of those days?
_____ hours per day
_____ minutes per day

Don’t know/Not sure
The last question is about the time you spent sitting on weekdays during the last 7
days. Include time spent at work, at home, while doing course work and during leisure
time. This may include time spent sitting at a desk, visiting friends, reading, or sitting or
lying down to watch television.
7. During the last 7 days, how much time did you spend sitting on a week day?
_____ hours per day
_____ minutes per day

Don’t know/Not sure
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